OPENING
07.30h UTC
Los Angeles-8h, Chicago-6h, Mexico City -6h, New York-5h, Panama -5h, Ouagadougou +0h, London +0h, Madrid +1h, Paris +1h, Rome +1h, Amsterdam +1h, Berlin +1h, Abuja +1h, Bucharest +2h, Helsinki +2, Cape Town +2h, Addis Ababa +3h, Nairobi +3h, Riyadh +3h, Tiblisi +4h, Abu Dhabi +4h, New Delhi +5.30h, Jakarta +7h, Beijing +8h, Tokyo +9h, Sydney +11h
——–
Massimo Sartelli (Italy)
–
World Antimicrobial Awareness Week (WAAW ) 2022
Diriba Mosissa (Antimicrobial Stewardship and Awareness Unit, Division of Antimicrobial Resistance, WHO)
—–
The importance of a multidisciplinary approach in preventing and treating infections in healthcare
Silvio Brusaferro (Italian National Institute of Health)
—
Infection prevention and management: why it’s so hard to really change our behavior
Maria Luisa Moro (Italian Multidisciplinary Society for the Prevention of Infections in Healthcare Organizations)
—-
Education and training in antimicrobial stewardship
Dilip Nathwani (Global Antimicrobial Stewardship Partnership Hub)
—–
SESSION 1
APPROPRIATE USE OF ANTIBIOTICS AND UNCONVENTIONAL THERAPY
08.45h UTC
Moderated by
Leonardo Pagani (Italy)
—–
Why prudent use of antibiotics
Pierre Tattevin (Alliance for the Prudent Use of Antibiotics)
——
Defining the impact of antibiotics on the intestinal microbiota to optimize antibiotic usage
Etienne Ruppe (France)
——
Phage therapy for multi-drug resistant Infections: certainties and controversies
Mariagrazia Di Luca (Italy)
—-
How to improve antibiotic awareness
Francesca Chiara (Antimicrobial Stewardship Project, Center for Infectious Disease Research and Policy)
—-
Invited to comment
Maria Elena Cocuz (Romania), Rahul Kamble (India)
——–
OPENING SESSION
THE GLOBAL BURDEN OF ANTIMICROBIAL RESISTANCE
10.15h UTC
Moderated by Fausto Catena (Italy)
—–
One health approach to tackling antimicrobial resistance
Sujith J. Chandy (ReAct Asia Pacific, India)
—-
The overlooked pandemic of antimicrobial resistance
Geetanjali Kapoor (Center for Disease Dynamics, Economics & Policy)
—-
Global priority research agenda on antimicrobial resistance in the human health sector
Silvia Bertagnolio (Control and Response Strategies Unit, Department of Control, Surveillance and Prevention of Antimicrobial Resistance, WHO)
—–
The European Union’s vision for antimicrobial resistance
John F. Ryan (Public health, country knowledge, crisis management, DG SANTE, European Commission, European Union)
—-
INTRA-ABDOMINAL INFECTIONS
SESSION 2
11:30h UTC
Moderated by
Vishal Shelat (Singapore)
—-
Classifications for intra-abdominal infections
Matti Tolonen (Finland)
—–
How to diagnose intra-abdominal infections
Sanjay Marwah (India)
—-
Prognostic scores for intra-abdominal infections. Can they be used in clinical practice?
Fikri Abu-Zidan (United Arab Emirates)
——
Invited to comment
Syed Muhammad Ali (Qatar), Gia Tomadze (Giorgia), Igor A. Kryvoruchko (Ukraine)
——
12.45 h UTC
Research in surgical infections: obstacles and opportunities (from APPAC I to APPAC III)
Paulina Salminen (Finland)
——
INTRA-ABDOMINAL INFECTIONS
SESSION 3
13.05h UTC
Moderated by
Luca Ansaloni (Italy)
—
Source control in intra-abdominal infections
Federico Coccolini (Italy)
——
Peritoneal swabs: when and how
Andreas Hecker (Germany)
—–
Microbiological tests in the era of antimicrobial resistance
Warren Lowman (South Africa)
——
Invited to comment
Ibrahima Sall (Senegal), Andee Dzulkarnaen Zakaria (Malaysia)
—–
INTRA-ABDOMINAL INFECTIONS
SESSION 4
14:20h UTC
Moderated by
Boris Sakakushev (Bulgaria)
—–
The ongoing threat of antimicrobial resistance in Gram-negative bacteria
Jesús Rodríguez Baño (Spain)
—–
Principles of antibiotic therapy in patients with intra-abdominal infections
Pierluigi Viale (Italy)
——
Optimal duration of antibiotic therapy for intra-abdominal infections
Robert Sawyer (USA)
—–
Invited to comment
Tadeja Pintar (Slovenia), Sumita Agarwal Jain (India)
—–
INTRA-ABDOMINAL INFECTIONS
SESSION 5
15:35h UTC
Moderated by
Raul Coimbra (USA)
—–
Invasive candidiasis in patients with intra-abdominal infections. When and how to treat intra-abdominal candidiasis
Philippe Montravers (France)
—-
Management of intra-abdominal infections in critically ill patients
Therese Duane (USA)
—–
Principles of antibiotic therapy in critically ill patients
Jan J De Waele (Belgium)
—–
Invited to comment
Samir Delibegovic (Bosnia and Herzegovina), Adrien Hodonou (Benin)
—–
16:50h UTC
The role of surgeons in preventing and treating infections in surgery
E. Patchen Dellinger (USA)
——
INTRA-ABDOMINAL INFECTIONS
SESSION 5
17:15h UTC
Moderated by
Mauro Podda (Italy)
—–
The management of intra-abdominal infections and sepsis in elderly critically ill patients: defining the line between utility and futility.
Massimo Antonelli (Italy)
—-
Relaparotomy strategy. When and how.
Marja Boermeester (The Netherlands)
—–
Damage control surgery strategy in patients with severe intra-abdominal infections.
Andrew Kirkpatrick (Canada)
—–
Invited to comment
Alibrahim Yahya (Libia), Carlos Augusto Gomes (Brazil)
—–
ANTIMICROBIAL STEWARDSHIP
SESSION 6
18:30h UTC
Moderated by Fabio Tumietto (Italy)
—-
Core components of global antimicrobial stewardship programs
Debra Goff (USA)
—–
Antimicrobial Stewardship in resource-poor settings
Abdoul Salam Ouédraogo (Burkina Faso)
—–
COVID-19 and antimicrobial stewardship lessons learned best practices and future implications
Alfredo Ponce-de-Leon (Mexico)
—–
Measurement of Performance in Antimicrobial Stewardship
Majdi N Al-Hasan (USA)
——
Invited to comment
Ana Belén Araúz (Panama), Abdul-Wahab Omo-ope Ettu (Nigeria)
——
20:00h UTC
Together we can impact millions of people. Achieving better health outcomes for vulnerable populations and communities through collaborative research
Tanya Zakrison (USA)
—
CLOSING
20.20h UTC